Notícias e Atividades da BioXcel

BioXcel é uma das ...

• Russell 3000;
• TOB Iconic 10,000.

BioXcel é uma empresa listada sob o símbolo BTAI (US).

Veja o organograma con seus 16 executivos principais

Biografias mais buscadas da BioXcel

• Vimal Mehta, Chief Executive Officer
• Michal Votruba, Director
• Michael Miller, Board Member

Criar um alerta
para seguir os movimentos de executivos da BioXcel.

BioXcel possui 2.350 concorrentes concorrentes Eurofins (Luxemburgo), Lonza (Suíça) e Genus (Reino Unido).

Popular M&A news in Biotecnologia

• Transcarent and Accolade have merged  (publicado em 9 de abril de 2025)..
• Kashiv BioSciences acaba de anunciar uma arrecadação de fundos de 150 milhões de dólares. (publicado em 7 de abril de 2025).
• Atsena Therapeutics acaba de anunciar uma arrecadação de fundos de 150 milhões de dólares. (publicado em 4 de abril de 2025).

Outros contatos sugeridos na indústria do Biotecnologia

• Kristina Burow - Director da Scholar Rock
• Steven Gillis - Chairman of the Board da VBI Vaccines
• Ali Behbahani - Non-Executive Director da Adaptimmune Therapeutics

Saiba mais sobre a indústria do Biotecnologia

Últimos comunicados de imprensa de BioXcel

• BioXcel Therapeutics to Highlight Novel Approaches in AI-Based Drug Candidate Discovery and Development and Advances in Neuroscience Portfolio at Virtual R&D Day :: BioXcel Therapeutics, Inc. (BTAI)
• BioXcel Therapeutics Presents Results from Ongoing Phase 2 Trial of BXCL701 in Combination with KEYTRUDA® in Aggressive Forms of Prostate Cancer at ESMO :: BioXcel Therapeutics, Inc. (BTAI)
• BioXcel Therapeutics to Present Updates from Ongoing Trial of BXCL701 in Aggressive Forms of Prostate Cancer at 2021 ESMO Congress :: BioXcel Therapeutics, Inc. (BTAI)
• BioXcel Therapeutics to Host Virtual R&D Day on September 23, 2021 :: BioXcel Therapeutics, Inc. (BTAI)
• BioXcel Therapeutics Reports Second Quarter 2021 Financial Results and Recent Operational Highlights :: BioXcel Therapeutics, Inc. (BTAI)
• BioXcel Therapeutics to Report Second Quarter 2021 Financial Results on August 10, 2021 :: BioXcel Therapeutics, Inc. (BTAI)
• BioXcel Therapeutics to Present at Canaccord Genuity 41st Annual Growth Conference :: BioXcel Therapeutics, Inc. (BTAI)
• BioXcel Therapeutics Announces Pricing of Public Offering of Common Stock :: BioXcel Therapeutics, Inc. (BTAI)
• BioXcel Therapeutics Announces Proposed Public Offering of Common Stock :: BioXcel Therapeutics, Inc. (BTAI)
• BioXcel Therapeutics to Host Virtual Commercial Day on June 25, 2021 :: BioXcel Therapeutics, Inc. (BTAI)
• View more press releases Close

Redes sociais sobre BioXcel

• BioXcel na Wikipedia, Google News e Yahoo Finance
• BioXcel na LinkedIn, Twitter e YouTube